ID   AS-1
AC   CVCL_DC71
DR   Wikidata; Q54750582
RX   Patent=US5024946;
RX   PubMed=2470715;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8118.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2710 ! RPMI-1788
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 11
//
RX   Patent=US5024946;
RA   Abe T., Fukumoto M.;
RT   "Human monoclonal antibody to antigen of gastric cancer and B-cell
RT   line for producing this antibody, method for preparing this B-cell
RT   line and antibody, antigen and method of preparation of this
RT   antigen.";
RL   Patent number US5024946, 18-Jun-1991.
//
RX   PubMed=2470715; DOI=10.1111/j.1349-7006.1989.tb02304.x;
RA   Abe T., Fukumoto M., Tsuchiya K., Kuramochi K., Furuta T., Togoh S.,
RA   Nishiyama K., Tsuchiya S.;
RT   "Human monoclonal antibodies against cytokeratin 18 generated from
RT   patients with gastric cancer.";
RL   Jpn. J. Cancer Res. 80:271-276(1989).
//